However, those in the chronic phase, known as chronic myeloid leukemia (CML), rely on BCR-ABL TKIs and are mostly not at a great chance of infection until and unless they do not respond or have poor response to treatment and other multiple comorbidities.[58,59]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.